Clinical Trial Update: Comparing the Effects of Spironolactone With Chlortalidone on LV Mass in Patients With CKD [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing spironolactone vs chlortalidone on left ventricular mass in patients with chronic kidney disease and cardio-renal syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardio-renal Syndrome
• Chronic Kidney Disease

Drugs mentioned

• Spironolactone (spironolactone)
• chlortalidone (chlortalidone)

Snippet

Sponsor: University Hospital Birmingham | Conditions: Renal Insufficiency, Chronic, Cardio-Renal Syndrome | Phase 4 | Status: UNKNOWN